Credit Suisse Lifts Price Targets For Drug Distributors After Solid Q2 Performance Credit Suisse raised the price target on Cigna Corporation (NYSE: CI ) from $315 to $329. The analyst raised the EPS estimate for 2022|2023 to $22.95|25.30. Credit Suisse notes that despite the positive trends experienced in 1H22, Cigna maintains a prudent outlook for the rest of the year. The management noted that, while utilization came in favorable in 2Q22, the company is not extrapolating this to 2H22 and is expecting a more normal utilization pattern, in-line with historical norms. Credit Suisse